Bixiye
P11-22 Billing Changes for Residential Treatment Centers and 1115 Waiver Providers for Minnesota Health Care Programs
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2022
Natiijooyinka Raadinta
Soo bandhiga 1841 - 1850 ee natiijooyinka 3688
Bixiye
P12-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates - Effective May 2, 2022
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2022
Bixiye
P13-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2022
Bixiye
QP17-22 Commercial Pharmacy Benefit Exclusion for Vabysmo™ and Xipere™
Taariikhda uu dhaqangalayo Barnaamijka: Mar 09, 2022
Bixiye
QP18-22 Minnesota Health Care Programs Housing Stabilization Referrals
Taariikhda uu dhaqangalayo Barnaamijka: Mar 09, 2022
Bixiye
QP19-22 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective May 1, 2022
Taariikhda uu dhaqangalayo Barnaamijka: Mar 09, 2022
Bixiye
2022 March Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2022
Bixiye
Tavneos™ (avacopan) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
Opzelura™ (ruxolitinib) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Des 01, 2024
Bixiye
QP22-22 Second Opinion Pilot for Select MSK Procedures Available to Commercial Fully Insured and Individual Members
Taariikhda uu dhaqangalayo Barnaamijka: Mar 09, 2022